Asker Healthcare Group AB (CHIX:ASKERS) EBIT: kr1,239 Mil (TTM As of Mar. 2026)


CHIX:ASKERS Asker Healthcare Group AB CHIX:ASKERS
20 GF Score
Price kr77.50
! 3 Warning Signs
View Full Analysis

What is Asker Healthcare Group AB EBIT?

Asker Healthcare Group AB CHIX:ASKERS 20 EBIT is kr1,239 Mil as of Mar. 2026. GuruFocus rates CHIX:ASKERS with a GF Score™ of 20/100. The stock has 3 warning signs investors should review.

Asker Healthcare Group AB's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was kr405 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was kr1,239 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Asker Healthcare Group AB's annualized ROC % for the quarter that ended in Mar. 2026 was 6.48%. Asker Healthcare Group AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 56.99%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Asker Healthcare Group AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 3.29%.


Asker Healthcare Group AB  (CHIX:ASKERs) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Asker Healthcare Group AB's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=1240 * ( 1 - 23.35% )/( (14212 + 15110)/ 2 )
=950.46/14661
=6.48 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Asker Healthcare Group AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1620/( ( (1779 + max(1149, 0)) + (1888 + max(869, 0)) )/ 2 )
=1620/( ( 2928 + 2757 )/ 2 )
=1620/2842.5
=56.99 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2052 + 2041 + 230) - (1678 + 0 + 1496)
=1149

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2153 + 2183 + 0) - (1698 + 0 + 1769)
=869

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Asker Healthcare Group AB's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=1239/37649.950
=3.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asker Healthcare Group AB EBIT Related Terms


Asker Healthcare Group AB EBIT Historical Data

* Premium members only.

The historical data trend for Asker Healthcare Group AB's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asker Healthcare Group AB EBIT Chart

Asker Healthcare Group AB Annual Data
Trend Dec22 Dec23 Dec24 Dec25
EBIT
721.00 572.00 861.00 870.00

Asker Healthcare Group AB Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 405.00 249.00 295.00 290.00 405.00

CHIX:ASKERS vs MCK, CAH, COR: EBIT Comparison

For the Medical Distribution subindustry, Asker Healthcare Group AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asker Healthcare Group AB EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Asker Healthcare Group AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Asker Healthcare Group AB's EV-to-EBIT falls into.


CHIX:ASKERS
20GF Score
Asker Healthcare Group AB CHIX:ASKERS
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asker Healthcare Group AB EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1,239 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of kr1,239 Mil mean?
Asker Healthcare Group AB (CHIX:ASKERS) has a EBIT of kr1,239 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Asker Healthcare Group AB.
Is Asker Healthcare Group AB's EBIT too high?
Asker Healthcare Group AB's current EBIT is kr1,239 Mil. Overall, Asker Healthcare Group AB has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's EBIT compare to MCK and CAH?
Asker Healthcare Group AB's EBIT of kr1,239 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Distribution company?
A good EBIT depends on the Medical Distribution industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Asker Healthcare Group AB. Asker Healthcare Group AB's current EBIT is kr1,239 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (CHIX:ASKERS) has a current EBIT of kr1,239 Mil. The current EBIT is kr1,239 Mil. Asker Healthcare Group AB's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Asker Healthcare Group AB (CHIX:ASKERS), the current EBIT is kr1,239 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Asker Healthcare Group AB Business Description

Other Exchanges ASKER:SwedenI88:Germany
Address Svardvagen 3A, Danderyd, SWE, 182 33
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
20GF Score

Get the complete analysis for CHIX:ASKERS

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr77.50
Price